Neurotech Reports Announces Investment and Management Conference for Bioelectronic Medicine The first investment and management conference for the bioelectronic medicine industry Source: Featured speakers include Gene Civillico, Ph. Also presenting is Eric Van Gieson, Ph. Sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.
To the Board of Directors Neurotech Development Corporation formerly Neurotech Corporation Manhasset, New York We have audited the accompanying consolidated balance sheets of Neurotech Development Corporation formerly Neurotech Corporation and Subsidiaries the Company as of June 30,andand the related consolidated statements of operations, changes in stockholders' equity deficit and cash flows for the years then ended.
These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
Except as discussed in the following paragraph, we conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement.
An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
|Heuro Canada is a neurotech company focused on neurological wellness.||The device helps to produce positive changes in the brain activity, balance, and behavior of children with autism spectrum disorder ASD. The trial compared Mente Autism with a control device over a 12 week period, and demonstrated significant reductions in brain wave frequency bands of interest—typically higher for children with ASD—for those using the device.|
|Neurotech announces a new distribution agreement in South Africa > מבדק מוקסו לאבחון ADHD||Our editors examine the major factors influencing the availability of venture capital to this industry and three different strategies for exploiting this current opportunity. Magnetic Stimulators Promise New Market While functional electrical stimulation has made tremendous progress in the development of neural prostheses, there are numerous impediments to rapid commercial growth, such as the requirement for surgical implantation.|
|In the News – Wireless Pain Relief | Stimwave||Image courtesy of Duke University Warren Grill was given a challenge in|
We were engaged as auditors subsequent to the year ended June 30, Therefore, we were unable to observe the physical inventory taken at June 30, andor the amount of inventory assumed by secured creditors insince those events occurred prior to our engagement as auditors.
The Company's records do not permit adequate retroactive tests of inventory quantities. Also, the Company sold a wholly-owned subsidiary effective July 1,and supporting documents for all transactions of that subsidiary were transferred to the new owner.
Therefore, sufficient, adequate documentation to support the and balance sheet amounts and theand statements of operations and cash flows amounts related to that subsidiary were not available for our inspection.
Accordingly, the scope of our work was not sufficient to enable us to express, and we do not express, an opinion on the consolidated balance sheets as of June 30, andor on the consolidated statements of operations and cash flows for each of the years in the three year period ended June 30, F-2 To the Board of Directors Neurotech Development Corporation In our opinion, the consolidated balance sheet as of June 30,presents fairly, in all material respects, the financial position of Neurotech Development Corporation and Subsidiaries at June 30,in conformity with generally accepted accounting principles.
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. These issues raise substantial doubt about the Company's ability to continue as a going concern.
Management's plans in regard to these matters are described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties. In addition, as discussed in Note 6, the Company is the defendant in a lawsuit alleging breeches of guarantee agreements relating to two promissory notes.
The ultimate outcome of the lawsuit cannot presently be determined, but management is of the opinion that it will not have a material impact on the Company's financial position. Accordingly, no provision for any additional liability that may result has been made in the consolidated balance sheet at June 30, Nevertheless, due to uncertainties with the lawsuit, it is at least reasonably possible that management's view of the outcome will change in the near future.
Fort Worth, Texas January 26, Neurotech Business Report is the first publication targeting the business of neurotechnology, the application of engineering techniques to human neural and information processing systems.
Nov 11, · A recent study by Neurotech Reports said the market for neurotechnology products is poised to become one of the most dramatic growth areas .
‘Neurotech Business Reports overviews the most recent business news from across the neurotechnology industry.’ ‘Three of these initiatives are overviewed below.’ ‘This article overviews significant developments in couple therapy over the last decade.’. WNDU in Indiana reports on the ongoing trial of the Monarch eTNS system, a collaboration between UCLA and the VA hospital, for veterans suffering from PTSD.
In the News.
December 6, » September 30th, » Neurotech Business Report - Vendor Profile NeuroSigma Pursues Multi-Pronged Strategy in Neurological Disorders Market (pdf. Prior to entering business development, he led the research and development of multiple early-stage technologies and products in cardiac rhythm management and heart failure.
Neurotech Reports is dedicated to providing business and technology professionals up-to-date and forward-looking information about the field of neurotechnology and. Traffic Management Operations.
AI solutions have been frequently applied in resolving control and optimization problems. Business leaders would find it interesting to note that AI is already being used in applications like prediction and detection of traffic accidents and conditions (by converting traffic sensors into ‘intelligent’ agents using cameras).